Join Eurofins at the 2019 DIA Annual Meeting in San Diego, CA

Posted by Jesse Gehris on Jun 3, 2019 9:15:00 AM

Eurofins BioPharma Services will be attending the DIA Global Annual Meeting in San Diego, CA, June 23-27! Join us at Booth 1705 to discover how our dedicated BioPharma laboratories provide seamless, end-to-end solutions to help customers progress through the drug development cycle through a single, experienced provider!

Read More

Tags: Central Laboratory, Quality, Clinical Trial, Drug Development, Development, BioPharma, Gene Therapy

Join Eurofins at the 2019 BIO Annual International Convention

Posted by Jesse Gehris on May 10, 2019 9:00:00 AM

Eurofins BioPharma Services will be attending the 2019 BIO International Convention in Philadelphia, June 3-6, to celebrate the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough. Join Eurofins BioPharma Services at Booth 2949 to consider how the largest wholly-owned network of BioPharma dedicated laboratories in the world can assist in your clinical trial research!

Read More

Tags: Central Laboratory, Quality, Results, Clinical Trial, BioPharma

Brexit Status Update - April 11, 2019

Posted by Sandra Hageman on Apr 11, 2019 11:28:33 AM

 

Update - April 11th, 2019

 

Read More

Tags: Central Laboratory, Clinical Trial, Brexit

Brexit - What's Next?

Posted by Sandra Hageman on Mar 29, 2019 9:28:23 AM

 

Update - March 29th, 2019

Last week, the United Kingdom (UK) and European Union (EU) reached an agreement on a postponement of the Brexit after ample discussions. As a result, the Brexit will not occur on Friday, March 29, 2019 as originally planned.

Actually today, March 29th, 2019, on the day the UK was due to leave the EU, MPs will have a third vote on the Withdrawal Agreement - the legally binding document that sets out the terms of the UK's departure from the EU. This includes a settlement, details of a transition period for after the UK leaves and protections for citizens' rights. It also includes the controversial backstop, or the insurance policy that aims to prevent a hard border returning to the island of Ireland.

Read More

Tags: Central Laboratory, Clinical Trial, Brexit

Join Us at ProcureCon PHARMA in Frankfurt, Germany March 19-20, 2019

Posted by Sandra Hageman on Mar 11, 2019 11:14:46 AM

 

Transforming Pharma Procurement. Together.

Eurofins BioPharma Services looks forward to meeting you at the ProcureCon PHARMA meeting in Frankfurt, Germany from March 19-20, 2019.

Read More

Tags: Central Laboratory, Clinical Trial, BioPharma, Leadership, Pharma Procurement

Newly Expanded Shanghai Facility

Posted by Jesse Gehris on Feb 26, 2019 11:52:02 AM

In 2017, China became the world's second-largest national pharmaceutical market, due to its aging population and rising medical needs. In its ongoing commitment to adapt to emerging trends in the pharmaceutical industry, Eurofins Central Laboratory,  a member of Eurofins BioPharma Services, has expanded its facility in Shanghai, China.

Read More

Tags: Central Laboratory, Clinical Trial, Development, Science Education, Shanghai

How To: Brexit-Proof Your Study

Posted by Sandra Hageman on Feb 12, 2019 10:18:32 AM

What is Brexit?

The deadline for the United Kingdom to withdraw from the European Union, known as Brexit, is quickly approaching. The formal date will be March 29, 2019. In June 2016, Britain held a national referendum on their European Union membership, and having to choose between remain and leave, the British voted to leave by 52%. After 18 months of negotiating a divorce plan on trade, security and migration matters with European Union, the deal was rejected by the British Parliament just 10 weeks before Britain is scheduled to leave the EU.

Read More

Tags: Central Laboratory, Clinical Trial, Brexit

Moebius Syndrome Awareness Day

Posted by Jesse Gehris on Jan 24, 2019 9:00:00 AM

Today we at Eurofins Central Laboratory recognize a rare neurological disorder known as Moebius Syndrome.

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Science Education, BioPharma, Moebius Syndrome

Cervical Health Awareness Month

Posted by Jesse Gehris on Jan 3, 2019 2:00:00 PM

Throughout the month, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, stands with the American Cancer Society to recognize January as Cervical Cancer Awareness Month. According to the World Health Organization (WHO):

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Cervical Cancer

FDA Approves New Treatment for Adult Patients With Rare, Life-Threatening Blood Disease (PNH)

Posted by Tracy Hendershott on Dec 24, 2018 9:00:00 AM

At Eurofins BioPharma Services, we feel this FDA press release, as a Christmas gift that came early! After working on multiple protocols, across multiple clients, we couldn't be happier to see the continued evolution of treatment solutions for this rare disease (around 2 cases per million). Prior to the first treatment being released in 2007, life expectancy of patient diagnosed with PNH was only ten years, with poor quality of life throughout that time. With the significant resource dedication of years of effort and capital, our peers and colleagues throughout the clinical trial industry have allowed patients to have:

Read More

Tags: FDA, Central Laboratory, Clinical Trial, PNH, New Treatment